Abstract:Metastasis is the cause of most triple-negative breast cancer deaths, yet anti-metastatic therapeutics remain limited. To develop new therapeutics to prevent metastasis, pathophysiologically relevant assays that recapitulate tumor microenvironment is essential for disease modeling and drug discovery. Here, we have developed a microfluidic metastasis-on-chip assay of the early stages of cancer metastasis integrated with the triple-negative breast cancer cell line (MDA-MB-231), stromal fibroblasts and a perfused microvessel. High-content imaging with automated quantification methods was optimized to assess the tumor cell invasion and intravasation within the model. Cell invasion and intravasation were enhanced when fibroblasts co-cultured with a breast cancer cell line (MDA-MB-231). However, the non-invasive breast cancer cell line, MCF7, remained non-invasive in our model, even in the presence of fibroblasts. High-content screening of a targeted anti-cancer therapy drug library was conducted to evaluate the drug response sensitivity of the optimized model. Through this screening, we identified 30 compounds that reduced the tumor intravasation by 60% compared to controls. Multi-parametric phenotypic analysis was applied by combining the data from the metastasis-on-chip, cell proliferation and 2D cell migration screens, revealing that the drug library was clustered into eight distinct groups with similar drug responses. Notably, MEK inhibitors were enriched in cluster cell invasion and intravasation. In contrast, drugs with molecular targets: ABL, KIT, PDGF, SRC, and VEGFR were enriched in the drug clusters showing a strong effect on tumor cell intravasation with less impact on cell invasion or cell proliferation, of which, Imatinib, a multi-kinase inhibitor targeting BCR-ABL/PDGFR/KIT. Further experimental analysis showed that Imatinib enhanced endothelial barrier stability as measured by trans-endothelial electrical resistance and significantly reduced the trans-endothelial invasion activity of tumor cells. Our findings demonstrate the potential of our metastasis-on-chip assay as a powerful tool for studying cancer metastasis biology, drug discovery aims, and assessing drug responses, offering prospects for personalized anti-metastatic therapies for triple-negative breast cancer patients.

Microfluidic Mapping of Cancer Cell-Protein Binding Interaction

In Situ Continuously Monitoring of Cancer Cell Invasion Process Based on Impedance Sensing

Integrated Microfluidic Platform with Multiple Functions To Probe Tumor-Endothelial Cell Interaction.

Microfluidic Cytometric Analysis of Cancer Cell Transportability and Invasiveness

Image-Assisted Microvessel-on-a-Chip Platform for Studying Cancer Cell Transendothelial Migration Dynamics

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

High-throughput 3D Cell Invasion Chip Enables Accurate Cancer Metastatic Assays.

Biological Gel-Based Microchamber Array for Tumor Cell Proliferation and Migration Studies in Well-Controlled Biochemical Gradients

Design and Construction of a Multi-Organ Microfluidic Chip Mimicking the in vivo Microenvironment of Lung Cancer Metastasis

A SERS-assisted 3D organotypic microﬂuidic chip for in-situ visualization and monitoring breast cancer extravasation process

Profiling of Immune-Cancer Interactions at the Single-Cell Level Using a Microfluidic Well Array.

Microfluidic Co-Culture System for Cancer Migratory Analysis and Anti-Metastatic Drugs Screening.

Quantitative Study of the Dynamic Tumor-Endothelial Cell Interactions Through an Integrated Microfluidic Coculture System.

Utilizing a High-Throughput Microdevice to Study Breast Tumor Cells Clustering and Metastasis

Interaction Study of Cancer Cells and Fibroblasts on a Spatially Confined Oxygen Gradient Microfluidic Chip to Investigate the Tumor Microenvironment

Microfluidic system for modelling 3D tumour invasion into surrounding stroma and drug screening

Cancer biophysics research in microfluidic landscapes

Insights into the mechanobiology of cancer metastasis via microfluidic technologies

In Situ Visualization and SERS Monitoring of the Interaction Between Tumor and Endothelial Cells Using 3D Microfluidic Networks

Development of a cancer metastasis-on-chip assay for high throughput drug screening

Family-Wide Photoproximity Profiling of Integrin Protein Social Networks in Cancer